Figure 2

Kaplan–Meier curves of patient outcomes according to chemo-effect and FOXA1 expression. (A, B) Patients who obtained pCR (n=9) showed better DFS and OS than the non-pCR group (n=94), although the differences were not statistically significant by log-rank test. (C, D) In the same manner, FOXA1-low tumours (n=34) tended to be associated with poorer patient outcomes than FOXA1-high tumours (n=69). (E, F) When pCR and non-pCR cases were compared only in the FOXA1-low population (n=34), the curves became wider, although the differences were still not significant based on the statistical method employed herein.